Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ghost Group is a venture capital and technology firm that specializes in the legal cannabis and medical marijuana industries. The company is best known as the parent of Weedmaps, a comprehensive technology platform that connects consumers with cannabis retailers and provides software solutions for the industry. Ghost Group focuses on investing in and building infrastructure, software, and consumer-facing technologies that support the medical and recreational cannabis markets. By providing a digital ecosystem for dispensaries and patients, the company plays a significant role in the commercialization and accessibility of medical marijuana products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ghost Group.